Skip to main content

Table 1 Participant characteristics

From: Patients’ experiences of continued treatment with extended-release naltrexone: a Norwegian qualitative study

Characteristic

Total N = 19

Age, mean (range), years

37.95 (22–55)

Sex, n (%)

 Male

15 (78.9)

 Female

4 (21.1)

Ethnicity, n (%)

 Norwegian

17 (89.5)

 Other

2 (10.5)

 In OTPs previous to study participation, n (%)

13 (68.4)

Most common living arrangements last three years, n (%)

 Alone

12 (63.2)

 With partner

4 (21)

 With parents or other family

3 (15.8)

 Currently living with someone with problematic drug/alcohol use, n (%)

0 (0)

 Years of completed education, mean (SD)

13.4 (2.5)

 Age at start of regular opioid use (yr), mean (SD)

25.4 (9.0)

 Length of regular opioid use (yr), mean (SD)

11.9 (7.0)

 XR-NTX injections received, mean (range)

7 [3–12]

 Number of XR-NTX injections received at interview time, n

  3

1

  4–6

6

  7–9

8

  10–12

4